Clover Health Investments, Corp. (NASDAQ:CLOV) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Clover Health Investments, Corp. (NASDAQ:CLOV - Free Report) by 90.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 830,457 shares of the company's stock after purchasing an additional 394,881 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.17% of Clover Health Investments worth $2,616,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in CLOV. Marshall Wace LLP grew its stake in Clover Health Investments by 167.6% during the 4th quarter. Marshall Wace LLP now owns 3,769,765 shares of the company's stock valued at $11,875,000 after purchasing an additional 2,360,902 shares during the last quarter. Millennium Management LLC lifted its holdings in shares of Clover Health Investments by 5,071.2% during the fourth quarter. Millennium Management LLC now owns 1,245,701 shares of the company's stock worth $3,924,000 after purchasing an additional 1,221,612 shares during the period. Teacher Retirement System of Texas purchased a new stake in Clover Health Investments in the fourth quarter valued at approximately $2,769,000. Schonfeld Strategic Advisors LLC acquired a new position in Clover Health Investments in the 4th quarter worth approximately $1,860,000. Finally, American Century Companies Inc. increased its holdings in Clover Health Investments by 181.0% in the 4th quarter. American Century Companies Inc. now owns 764,694 shares of the company's stock worth $2,409,000 after buying an additional 492,527 shares during the period. Hedge funds and other institutional investors own 19.77% of the company's stock.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group lifted their price objective on shares of Clover Health Investments from $4.20 to $4.50 and gave the company a "buy" rating in a research note on Monday, March 3rd.

Clover Health Investments Trading Up 0.3%

CLOV traded up $0.01 during midday trading on Tuesday, hitting $2.99. 4,300,980 shares of the company were exchanged, compared to its average volume of 6,646,991. The company's 50 day simple moving average is $3.40 and its 200 day simple moving average is $3.65. The firm has a market capitalization of $1.52 billion, a price-to-earnings ratio of -14.95 and a beta of 1.91. Clover Health Investments, Corp. has a 1-year low of $0.97 and a 1-year high of $4.87.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.12. Clover Health Investments had a negative return on equity of 25.46% and a negative net margin of 5.92%. The firm had revenue of $462.33 million for the quarter, compared to analyst estimates of $466.93 million. On average, equities analysts anticipate that Clover Health Investments, Corp. will post -0.12 EPS for the current year.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.